EPIDAREX CAPITAL II, LP

UK registered

Companies House number SL011942·8 UK shareholdings·1 ownership layers

EPIDAREX CAPITAL II, LP is a UK-registered corporate shareholder (Companies House number SL011942) and holds shares in 8 active UK companies, recorded across 15 share-class positions on their Companies House confirmation statements (CS01). Beneath those direct holdings OpenRegistry resolves a further 0 companies spanning 1 ownership layers; the persons-with-significant-control register independently agrees on 5 of these holdings. It ranks #2,330 of 54,210 corporate shareholders by number of active UK holdings. Programmatic access via MCP at https://openregistry.sophymarine.com/mcp.

Companies held
8

Share-class positions
15

Identity
UK company SL011942

Jurisdiction
UNITED KINGDOM

Ownership layers below
1

PSC register agrees on
5 holdings

Company profile

Companies House profile of EPIDAREX CAPITAL II, LP

Shareholders

Shares held by EPIDAREX CAPITAL II, LP in 8 UK companies

Ownership chain

0 companies across 1 layers beneath EPIDAREX CAPITAL II, LP

Official record

Companies House record SL011942

Shareholdings

Every company EPIDAREX CAPITAL II, LP appears on as a member, as filed. 8 of 8 are linked to their Companies House profile.

Company held	Status	Accounts	Share class	Shares	% of class	% of capital	Total % of capital	As of
ADORX THERAPEUTICS LIMITEDSC558719	Active		SERIES A SHARES	1,816,154	54.40%	47.56%	51.62%	2024-02-24
ADORX THERAPEUTICS LIMITEDSC558719	Active		DEFERRED SHARES	155,000	73.35%	4.06%	51.62%	2024-02-24
CLYDE BIOSCIENCES LIMITEDSC418838	Active	TOTAL EXEMPTION FULL	SERIES A	269,248	60.55%	40.60%	40.60%	2026-02-26
SIRAKOSS LIMITEDSC386423	Active		SERIES A	0		0.00%		2021-10-12
LEUCID BIO LTD09331486	Active		SEED PARTICIPATING PREFERENCE	916,666				2025-11-27
EPSILOGEN LTD10295520	Active	FULL	SERIES A2	363,636				2025-07-25
EPSILOGEN LTD10295520	Active	FULL	SERIES A	4,700,000				2025-07-25
ENTERPRISE THERAPEUTICS HOLDINGS LIMITED12868901	Active		PREFERRED SERIES B2	613,208				2025-09-08
			PREFERRED SERIES B1	439,179
			SERIES B	527,413
			SERIES A	2,199,300
EDINBURGH MOLECULAR IMAGING LIMITEDSC467269	Active	TOTAL EXEMPTION FULL	A PREFERRED	5,640,000				2024-01-13
MIRONID LIMITEDSC476430	Active	SMALL	SERIES A SHARES	89,076				2023-09-20
			SERIES A-1 SHARES	21,892
			SERIES A-2 SHARES	5,715

Related company owners

Corporate shareholders that hold shares in the same UK companies as EPIDAREX CAPITAL II, LP:

EPIDAREX CAPITAL III UK, LPSL033678 9 shared holdings
TOUCHSTONE INNOVATIONS BUSINESSES LLPOC333709 8 shared holdings
ALSA VENTURES I SCSP 8 shared holdings
BRITISH PATIENT CAPITAL LIMITED11271076 4 shared holdings
UTF GENERAL PARTNER LLPOC403211 4 shared holdings
ELI LILLY AND COMPANY LIMITED00284385 3 shared holdings

Other corporate shareholders of comparable size registered in UNITED KINGDOM:

THE LIVERPOOL FOOTBALL CLUB AND ATHLETIC GROUNDS LIMITED00035668 7 UK holdings
LUCY GROUP LTD00051908 7 UK holdings
WBG FINANCIAL LIMITEDSC676887 8 UK holdings
KAIZEN REAL ESTATE LTDSC707632 8 UK holdings

Every company on this page is identified by its original Companies House registration number, shown beside its name and repeated in the data-company-number attribute of the same element. A shareholder that does not resolve to a registered company carries no number.

▼ marks a holding that itself holds shares in further companies, so ownership continues below it.

“% of capital” is the entity’s share of issued capital by nominal value, the correct basis when a company has multiple share classes.

Figures are as filed on each company’s most recent confirmation statement; the “As of” column gives that statement date. Source: Companies House Free Company Data and CS01 confirmation statements. Official record: find-and-update.company-information.service.gov.uk.